Abbott Laboratories

ABT: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
hblLOCK|p@ddvLOCK|<vhgM^g

Abbott Earnings: Softness in Diagnostics Causes Management to Lower Outlook for 2025

Abbott posted second-quarter results that featured 7% top-line constant-currency growth and 120 basis points of operating margin improvement, but lowered guidance due to lingering covid and China weakness.

Sponsor Center